ALEXANDRIA, Va., July 23 -- United States Patent no. 12,367,959, issued on July 22, was assigned to ROM Technologies Inc. (Brookfield, Conn.).
"System and method for using AI/ML to generate treatment plans to stimulate preferred angiogenesis" was invented by Joel Rosenberg (Brookfield, Conn.) and Steven Mason (Las Vegas, Conn.).
According to the abstract* released by the U.S. Patent & Trademark Office: "A computer-implemented system includes a processing device configured to receive a plurality of user and blood vessel characteristics associated with a user, generate a selected set of user and blood vessel characteristics, determine, based on the selected set of the user and blood vessel characteristics, a probability that angiogenesis wi...